Picture of Alkermes logo

ALKSV — Alkermes News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapNeutral

Alkermes Plc expected to post earnings of 1  cent a share - Earnings Preview

* Alkermes Plc  ALKS.OQ   ALKS.O  is expected to show a fall
in
quarterly revenue when it reports  results 
    * The Dublin-based  company is expected to report  a
11.7% decrease in revenue to $268.237 million from $303.72
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Alkermes Plc is for
earnings of 1 cent per share. For the same quarter last year,
the company reported earnings of 30 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 188.2%
in the last three months. ​
    * Wall Street's median 12-month price target for Alkermes
Plc is
$32.5​, above​ its last closing price of $29.68. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  0.01        0.01       0.12      Beat    1,066.
                                                        2
 Dec. 31 2022  0.08        0.08       0.23      Beat    182.5
 Sep. 30 2021  0.09        0.06       0.14      Beat    125.8​
 Jun. 30 2021  0.15        0.12       0.30      Beat    147.1
 ​​Mar.        -0.02       -0.02      0.11      Beat    718.8
 31 2021                                                
 Dec. 31 2020  0.07        0.07       0.10      Beat    40.8​
 Sep. 30 2020  0.01        0.00       0.26      Beat    12,900
 Jun. 30 2020  0.03        -0.01      0.06      Beat    600
 This summary was machine generated July 15 at 13:26 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Alkermes

See all news